Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 49,328 | 51,524 | 33,923 | 29,907 | 32,476 |
| Operating Income | -49,328 | -51,524 | -33,923 | -29,907 | -32,476 |
| Interest Expense | 0 | 4 | 391 | 1,163 | 1,202 |
| Other Income | 6,505 | 3,587 | 5,217 | 1,882 | -283 |
| Pre-tax Income | -42,823 | -47,941 | -29,097 | -29,188 | -33,961 |
| Income Tax | -64 | -30 | -32 | -36 | -21 |
| Net Income Continuous | -42,759 | -47,911 | -29,065 | -29,152 | -33,940 |
| Net Income | $-42,759 | $-47,911 | $-29,065 | $-29,152 | $-33,940 |
| EPS Basic Total Ops | -0.32 | -0.47 | -0.29 | -0.45 | -1.49 |
| EPS Basic Continuous Ops | -0.32 | -0.47 | -0.29 | -0.45 | -1.49 |
| EPS Diluted Total Ops | -0.32 | -0.47 | -0.29 | -0.45 | -1.49 |
| EPS Diluted Continuous Ops | -0.32 | -0.47 | -0.29 | -0.45 | -1.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.47 | -0.29 | -0.45 | -1.49 |
| EBITDA(a) | $-49,184 | $-51,377 | $-33,620 | $-29,344 | $-31,827 |